194 related articles for article (PubMed ID: 16787157)
1. Increasing speed and throughput when using HPLC-MS/MS systems for drug metabolism and pharmacokinetic screening.
Hsieh Y; Korfmacher WA
Curr Drug Metab; 2006 Jun; 7(5):479-89. PubMed ID: 16787157
[TBL] [Abstract][Full Text] [Related]
2. HPLC-MS/MS in drug metabolism and pharmacokinetic screening.
Hsieh Y
Expert Opin Drug Metab Toxicol; 2008 Jan; 4(1):93-101. PubMed ID: 18370861
[TBL] [Abstract][Full Text] [Related]
3. Potential of HILIC-MS in quantitative bioanalysis of drugs and drug metabolites.
Hsieh Y
J Sep Sci; 2008 May; 31(9):1481-91. PubMed ID: 18428187
[TBL] [Abstract][Full Text] [Related]
4. Ultra-performance liquid chromatography/tandem mass spectrometric quantification of structurally diverse drug mixtures using an ESI-APCI multimode ionization source.
Yu K; Di L; Kerns E; Li SQ; Alden P; Plumb RS
Rapid Commun Mass Spectrom; 2007; 21(6):893-902. PubMed ID: 17295426
[TBL] [Abstract][Full Text] [Related]
5. 'LC-electrolyte effects' improve the bioanalytical performance of liquid chromatography/tandem mass spectrometric assays in supporting pharmacokinetic study for drug discovery.
Wang L; Sun Y; Du F; Niu W; Lu T; Kan J; Xu F; Yuan K; Qin T; Liu C; Li C
Rapid Commun Mass Spectrom; 2007; 21(16):2573-84. PubMed ID: 17639570
[TBL] [Abstract][Full Text] [Related]
6. Utility of mass spectrometry for in-vitro ADME assays.
Chu I; Nomeir AA
Curr Drug Metab; 2006 Jun; 7(5):467-77. PubMed ID: 16787156
[TBL] [Abstract][Full Text] [Related]
7. Sensitive determination of a pharmaceutical compound and its metabolites in human plasma by ultra-high performance liquid chromatography-tandem mass spectrometry with on-line solid-phase extraction.
Heinig K; Wirz T; Bucheli F; Monin V; Gloge A
J Pharm Biomed Anal; 2011 Mar; 54(4):742-9. PubMed ID: 21051172
[TBL] [Abstract][Full Text] [Related]
8. Application of mass spectrometry for metabolite identification.
Ma S; Chowdhury SK; Alton KB
Curr Drug Metab; 2006 Jun; 7(5):503-23. PubMed ID: 16787159
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous fast HPLC-MS/MS analysis of drug candidates and hydroxyl metabolites in plasma.
Hsieh Y; Brisson JM; Wang G; Ng K; Korfmacher WA
J Pharm Biomed Anal; 2003 Sep; 33(2):251-61. PubMed ID: 12972090
[TBL] [Abstract][Full Text] [Related]
10. Direct cocktail analysis of drug discovery compounds in pooled plasma samples using liquid chromatography-tandem mass spectrometry.
Hsieh Y; Bryant MS; Brisson JM; Ng K; Korfmacher WA
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Feb; 767(2):353-62. PubMed ID: 11885864
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in use of LC/MS/MS for quantitative high-throughput bioanalytical support of drug discovery.
Ackermann BL; Berna MJ; Murphy AT
Curr Top Med Chem; 2002 Jan; 2(1):53-66. PubMed ID: 11899065
[TBL] [Abstract][Full Text] [Related]
12. Use of a five-channel multiplexed electrospray quadrupole time-of-flight hybrid mass spectrometer for metabolite identification.
Leclercq L; Delatour C; Hoes I; Brunelle F; Labrique X; Castro-Perez J
Rapid Commun Mass Spectrom; 2005; 19(12):1611-8. PubMed ID: 15915450
[TBL] [Abstract][Full Text] [Related]
13. The role of hyphenated chromatography-mass spectrometry techniques in exploratory drug metabolism and pharmacokinetics.
Hsieh Y; Korfmacher W
Curr Pharm Des; 2009; 15(19):2251-61. PubMed ID: 19601826
[TBL] [Abstract][Full Text] [Related]
14. LC-MS Development strategies for quantitative bioanalysis.
Jemal M; Xia YQ
Curr Drug Metab; 2006 Jun; 7(5):491-502. PubMed ID: 16787158
[TBL] [Abstract][Full Text] [Related]
15. Separation and sample pre-treatment in bioanalysis using monolithic phases: A review.
Saunders KC; Ghanem A; Boon Hon W; Hilder EF; Haddad PR
Anal Chim Acta; 2009 Oct; 652(1-2):22-31. PubMed ID: 19786168
[TBL] [Abstract][Full Text] [Related]
16. Validated assay for the simultaneous quantification of total vincristine and actinomycin-D concentrations in human EDTA plasma and of vincristine concentrations in human plasma ultrafiltrate by high-performance liquid chromatography coupled with tandem mass spectrometry.
Damen CW; Israëls T; Caron HN; Schellens JH; Rosing H; Beijnen JH
Rapid Commun Mass Spectrom; 2009 Mar; 23(6):763-74. PubMed ID: 19204931
[TBL] [Abstract][Full Text] [Related]
17. Turbulent flow bioanalysis in drug metabolism and pharmacokinetics.
Rudewicz PJ
Bioanalysis; 2011 Jul; 3(14):1663-71. PubMed ID: 21756098
[TBL] [Abstract][Full Text] [Related]
18. An integrated bioanalytical platform for supporting high-throughput serum protein binding screening.
Zhang J; Shou WZ; Vath M; Kieltyka K; Maloney J; Elvebak L; Stewart J; Herbst J; Weller HN
Rapid Commun Mass Spectrom; 2010 Dec; 24(24):3593-601. PubMed ID: 21080511
[TBL] [Abstract][Full Text] [Related]
19. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
20. Response normalized liquid chromatography nanospray ionization mass spectrometry.
Ramanathan R; Zhong R; Blumenkrantz N; Chowdhury SK; Alton KB
J Am Soc Mass Spectrom; 2007 Oct; 18(10):1891-9. PubMed ID: 17766144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
